The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration

Published:2019-04-11 Issue:5 Volume:60 Page:1470
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Brown Emily E.¹²,Ball Jacob D.³,Chen Zhaoyi³,Khurshid Gibran S.¹,Prosperi Mattia³,Ash John D.¹

Affiliation:

1. Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States

2. Clinical and Translational Science Institute, University of Florida, Gainesville, Florida, United States

3. Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Oral Pharmaceuticals for Dry Age-Related Macular Degeneration: Mechanism of Action, Current Clinical Status, and Future Directions;Ophthalmic Surgery, Lasers and Imaging Retina;2024-09

2. Metformin Alleviates Inflammation and Induces Mitophagy in Human Retinal Pigment Epithelium Cells Suffering from Mitochondrial Damage;Cells;2024-08-27

3. The role of oral metformin in preventing and treating age-related macular degeneration: A meta-analysis;Medicine;2024-07-12

4. Mitochondrial quality control in non-exudative age-related macular degeneration: From molecular mechanisms to structural and functional recovery;Free Radical Biology and Medicine;2024-07

5. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks;Ageing Research Reviews;2024-07